The future of continuous glucose monitoring

Diabetes Technology and Therapeutics

Volumn 11, Issue SUPPL.1, 2009, Pages

  Garg, Satish K ^a,b,c  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b Diabetes Technology and Therapeutics   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY MONITORING; BLOOD; ECONOMICS; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MONITORING; SELF CARE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; MONITORING, AMBULATORY; MONITORING, PHYSIOLOGIC; SELF CARE;

EID: 84867148229     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2008.0105     Document Type: Editorial

References (36)

1. Hogan P, Dall T, Nikolov P; American Diabetes Association: Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
2. American Diabetes Association: Economic costs of diabetes in the US in 2007. Diabetes Care 2008;31:1-20.
3. Ettaro L, Songer TJ, Zhang P, Engelgau MM: Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004;22: 140-164.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulindependent diabetes mellitus. The Diabetes Control and Complication Trial Research Group. N Engl J Med 1993;329: 977-986.
5. Writing Team for the Diabetes Control and Complication Trial=Epidemiology of Diabetes Interventions and Complications Research Study: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetes nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167.
6. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial=Epidemiology of Diabetes Interventions and Complications (DCCT=EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
7. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-1912. (Pubitemid 36929141)
8. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by active glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
9. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type I diabetes-response to the Diabetes Research in Children Network (Direc Net) Study Group. Diabetes Care 2007;30: 187-188. (Pubitemid 46052531)
10. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
11. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649. (Pubitemid 44912192)
12. Tierney MJ, Tamada JA, Potta RO, Jovanovic L, Garg S; Cygnus Research Team: Clinical evaluation of the Gluco-Watch® Biographer: a continual non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron 2001;16: 621-629. (Pubitemid 33000190)
13. Garg SK, Hoff HK, Chase HP: The role of continuous glucose sensors in diabetes care. Endocrinol Metab Clin North Am 2004;33:163-173. (Pubitemid 38438429)
14. Chase HP, Roberts MD, Wightman C, Klingensmith G, Garg SK, Van Wyhe M, Desai S, Harper W, Lopatin M, Bartkowiak M, Tamada J, Eastman RC: Use of the Gluco Watch Biographer in children with type 1 diabetes. Pediatrics 2003;111: 790-794. (Pubitemid 36402903)
15. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
16. Bailey TS, Zisser HC, Garg SK: Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 2007;9:203-210. (Pubitemid 46959785)
17. Deiss D, Bolinder J, Riveline J, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732. (Pubitemid 44912209)
18. Garg SK, Kelly WC, Voelmle MK, Ritchie PJ, Gottlieb PA, McFann KK, Ellis SL: Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care 2007;30:3023-3025. (Pubitemid 350255236)
19. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27: 734-738. (Pubitemid 38280542)
20. Ellis SL, Bookout T, Garg SK, Izuora KE: Use of continuous glucosemonitoring to improve diabetes mellitus management. Endocrinol Metab Clin North Am 2008;36(Suppl 2): 47-68.
21. Edelman SV, Bailey T.S: Continuous glucose monitoring health outcomes. Diabetes Technol Ther 2009;11(Suppl 1): S-68-S-74.
22. Fabiato K, Buse J, Duclos M, Largay J, Izlar C, O'Connell T, Stallings J, Dungan K: Clinical experience with continuous glucose monitoring in adults. Diabetes Technol Ther 2009; 11(Suppl 1):S-93-S-103.
23. Skyler JS: Continuous glucose monitoring: an overview of its development. Diabetes Technol Ther 2009;11(Suppl 1): S-5-S-10.
24. McGarraugh G: The chemistry of commercial continuous glucose monitors. Diabetes Technol Ther 2009;11(Suppl 1): S-17-S-24.
25. Brauker J: continuous glucose sensing: future technology developments. Diabetes Technol Ther 2009;11(Suppl 1):S-25-S-36.
26. Garg SK: Role of emerging new technologies. Diabetes Technol Ther 2008;10:413-414.
27. Cengiz E, Tamborlane WV: A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther 2009;11(Suppl 1):S-11-S-16.
28. Clarke W, Kovatchev B: Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009; 11(Suppl 1):S-45-S-54.
29. Kowalski AJ: Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. Diabetes Technol Ther 2009;11(Suppl 1):S-113-S-119.
30. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA: Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008;10:377-383.
31. Hirsch IB: Continuous glucose monitoring: understanding our current culture. Diabetes Technol Ther 2009;11(Suppl 1): S-131-S-132.
32. Orzeck EA: Maximizing reimbursement through correct coding initiatives. Diabetes Technol Ther 2009;11(Suppl 1): S-121-S-127.
33. Chitayat L, Zisser H, Jovanovic L: Continuous glucose monitoring during pregnancy. Diabetes Technol Ther 2009; 11(Suppl 1):S-105-S-111.
34. Wadwa RP, Fiallo-Scharer R, Vander Wel B, Messer LH, Cobry E, Chase HP: Continuous glucose monitoring in youth with type 1 diabetes. Diabetes Technol Ther 2009;11(Suppl 1): S-83-S-91.
35. Voelmle MK, Ritchie PJ, Naik RG, Garg SK: Improved A1c values with in increase in hypoglycemia in pregnant women with type 1 diabetes using real-time continuous home glucose monitors [abstract]. Diabetes 2008;57(Suppl 1):A117-A118.
36. Peters A: Do we really need continuous glucose monitoring? Diabetes Technol Ther 2009;11(Suppl 1):S-128-S-130.